Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1244]

ASCO 2012: Advances in lymphoma; bendamustine combination in indolent lymphoma

Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Mathias...

ASCO 2012: Advances in lymphoma; bendamustine combination in indolent lymphoma ( Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Mathias Rummel - University Hospital Giessen, Germany )

ASCO 2012: Advances in metastatic castration-resistant prostate cancer; first...

Dr Chris Parker - Royal Marsden Cancer Centre, London, UK; Prof Stéphan Oudard...

ASCO 2012: Advances in metastatic castration-resistant prostate cancer; first-line cabazitaxel ( Dr Chris Parker - Royal Marsden Cancer Centre, London, UK; Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, France )

Increased risk of breast cancer among young women treated with radiation as a...

Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA

Increased risk of breast cancer among young women treated with radiation as a child ( Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA )

First effective treatment for chemotherapy-induced peripheral neuropathy

Dr Ellen Lavoie Smith - University of Michigan, Ann Arbor, USA

First effective treatment for chemotherapy-induced peripheral neuropathy ( Dr Ellen Lavoie Smith - University of Michigan, Ann Arbor, USA )

Regorafenib effective for GISTs that progress due to resistance to approved...

Dr George Demetri - Dana Farber Cancer Institute, Boston, USA

Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana Farber Cancer Institute, Boston, USA )

Combined chemo-radiation extends survival in patients with anaplastic...

Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam...

Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours ( Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam, Netherlands )

Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer...

Dr Eric Pujade-Lauraine - Université Paris Descartes, France

Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improves progression-free survival ( Dr Eric Pujade-Lauraine - Université Paris Descartes, France )

Primary and secondary resistance in colorectal cancer

Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy

Primary and secondary resistance in colorectal cancer ( Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy )

PI3K and the heterogeneity of small tumour breast cancer

Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium

PI3K and the heterogeneity of small tumour breast cancer ( Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium )

Molecularly characterising triple negative breast cancer

Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium

Molecularly characterising triple negative breast cancer ( Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium )

Endocrine therapy and endocrine resistant breast cancer

Prof Mitch Dowsett – The Institute for Cancer Research, London, UK

Endocrine therapy and endocrine resistant breast cancer ( Prof Mitch Dowsett – The Institute for Cancer Research, London, UK )

Use of metformin against breast cancer

Prof Alastair Thompson – University of Dundee, UK

Use of metformin against breast cancer ( Prof Alastair Thompson – University of Dundee, UK )

More from ecancer